PL1817347T3 - Sposób sieciowania kwasu hialuronowego za pomocą diwinylosulfonu - Google Patents

Sposób sieciowania kwasu hialuronowego za pomocą diwinylosulfonu

Info

Publication number
PL1817347T3
PL1817347T3 PL05804061T PL05804061T PL1817347T3 PL 1817347 T3 PL1817347 T3 PL 1817347T3 PL 05804061 T PL05804061 T PL 05804061T PL 05804061 T PL05804061 T PL 05804061T PL 1817347 T3 PL1817347 T3 PL 1817347T3
Authority
PL
Poland
Prior art keywords
divinylsulfone
cross
hyaluronic acid
linking hyaluronic
linking
Prior art date
Application number
PL05804061T
Other languages
English (en)
Inventor
Fanny Longin
Khadija Schwach-Abdellaoui
Original Assignee
Albumedix As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Albumedix As filed Critical Albumedix As
Publication of PL1817347T3 publication Critical patent/PL1817347T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/738—Cross-linked polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Materials Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL05804061T 2004-11-24 2005-11-24 Sposób sieciowania kwasu hialuronowego za pomocą diwinylosulfonu PL1817347T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200401824 2004-11-24
EP05804061.9A EP1817347B1 (en) 2004-11-24 2005-11-24 Method of cross-linking hyaluronic acid with divinylsulfone
PCT/DK2005/000753 WO2006056204A1 (en) 2004-11-24 2005-11-24 Method of cross-linking hyaluronic acid with divinylsulfone

Publications (1)

Publication Number Publication Date
PL1817347T3 true PL1817347T3 (pl) 2017-10-31

Family

ID=36051535

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05804061T PL1817347T3 (pl) 2004-11-24 2005-11-24 Sposób sieciowania kwasu hialuronowego za pomocą diwinylosulfonu

Country Status (8)

Country Link
US (3) US8481080B2 (pl)
EP (1) EP1817347B1 (pl)
CN (1) CN101107270B (pl)
DK (1) DK1817347T3 (pl)
ES (1) ES2636998T3 (pl)
PL (1) PL1817347T3 (pl)
PT (1) PT1817347T (pl)
WO (1) WO2006056204A1 (pl)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
FR2909560B1 (fr) * 2006-12-06 2012-12-28 Fabre Pierre Dermo Cosmetique Gel d'acide hyaluronique pour injection intradermique
EP2107913B1 (en) 2006-12-22 2012-02-15 Croma-Pharma Gesellschaft m.b.H. Use of thiolated polysaccharides for tissue augmentation
JP2008255061A (ja) * 2007-04-06 2008-10-23 Shiseido Co Ltd 可溶性架橋ヒアルロン酸含有眼用組成物
CA2687990A1 (en) 2007-05-23 2008-12-04 Allergan, Inc. Cross-linked collagen and uses thereof
US20110077737A1 (en) * 2007-07-30 2011-03-31 Allergan, Inc. Tunably Crosslinked Polysaccharide Compositions
CN101821294B (zh) 2007-09-28 2012-10-31 株式会社资生堂 溶胀性交联透明质酸粉末及其制造方法
US8697044B2 (en) 2007-10-09 2014-04-15 Allergan, Inc. Crossed-linked hyaluronic acid and collagen and uses thereof
PT2818184T (pt) 2007-11-16 2019-01-28 Aclaris Therapeutics Inc Composições e métodos para o tratamento de púrpura
US8394784B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having multi-stage bioactive agent delivery
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
WO2009077399A1 (en) * 2007-12-19 2009-06-25 Evonik Goldschmidt Gmbh Crosslinked hyaluronic acid in emulsion
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
CA2735173C (en) 2008-09-02 2017-01-10 Tautona Group Lp Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
DK2413894T3 (en) * 2009-04-02 2017-04-03 Allergan Inc HIGHLY FORMED HYDROGLES FOR SOFTWARE STRENGTH
US9371402B2 (en) * 2009-04-09 2016-06-21 Scivision Biotech Inc. Method for producing cross-linked hyaluronic acid
FR2945293B1 (fr) 2009-05-11 2011-06-17 Teoxane Procede de preparation d'un gel reticule.
BR112012002117A2 (pt) 2009-07-30 2019-09-24 Carbylan Biosurgery Inc composições poliméricas modificadas de ácido hialurônico e métodos relacionados.
CZ302503B6 (cs) 2009-12-11 2011-06-22 Contipro C A.S. Zpusob prípravy derivátu kyseliny hyaluronové oxidovaného v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd a zpusob jeho modifikace
CZ2009836A3 (cs) 2009-12-11 2011-06-22 Contipro C A.S. Derivát kyseliny hyaluronové oxidovaný v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd, zpusob jeho prípravy a zpusob jeho modifikace
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
US8586562B2 (en) 2010-03-12 2013-11-19 Allergan Industrie, Sas Fluid compositions for improving skin conditions
EP4062950A1 (en) 2010-03-22 2022-09-28 Allergan, Inc. Syringe comprising dermal filler for soft tissue augmentation
AU2010350075B2 (en) * 2010-03-30 2016-03-03 Histocell, S.L. New biomaterial from Wharton's jelly umbilical cord
US8697057B2 (en) 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
FR2968305B1 (fr) 2010-12-06 2014-02-28 Teoxane Procede de preparation d'un gel reticule
CZ302994B6 (cs) 2010-12-31 2012-02-08 Cpn S.R.O. Hyaluronová vlákna, zpusob jejich prípravy a použití
DK2699274T3 (en) 2011-04-20 2015-06-15 Carbylan Therapeutics Inc In situ gelling formations
CN102757572A (zh) * 2011-04-28 2012-10-31 上海其胜生物制剂有限公司 一种具有双抗特性(抗高温、酶解)的无颗粒化交联透明质酸钠凝胶的制备方法
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
RU2624239C2 (ru) 2011-06-03 2017-07-03 Аллерган, Инк. Составы кожного наполнителя, включая антиоксиданты
RU2613887C2 (ru) 2011-08-10 2017-03-21 Гликорес 2000 С.Р.Л. Устойчивый к расщеплению сшитый низкомолекулярный гиалуронат
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
CZ303879B6 (cs) 2012-02-28 2013-06-05 Contipro Biotech S.R.O. Deriváty na bázi kyseliny hyaluronové schopné tvorit hydrogely, zpusob jejich prípravy, hydrogely na bázi techto derivátu, zpusob jejich prípravy a pouzití
CZ304512B6 (cs) 2012-08-08 2014-06-11 Contipro Biotech S.R.O. Derivát kyseliny hyaluronové, způsob jeho přípravy, způsob jeho modifikace a použití
FR2997014B1 (fr) 2012-10-24 2015-03-20 Teoxane Composition sterile dermo-injectable
FR2997085B1 (fr) 2012-10-24 2015-05-29 Teoxane Procede de preparation d'un gel reticule
CZ304654B6 (cs) * 2012-11-27 2014-08-20 Contipro Biotech S.R.O. Nanomicelární kompozice na bázi C6-C18-acylovaného hyaluronanu, způsob přípravy C6-C18-acylovaného hyaluronanu, způsob přípravy nanomicelární kompozice a stabilizované nanomicelární kompozice a použití
WO2014096257A1 (en) * 2012-12-19 2014-06-26 Novozymes Biopharma Dk A/S Freeze-dried cross-linked hyaluronic acid sponge
US20200230033A1 (en) * 2013-01-21 2020-07-23 Paean Aesthetics Inc. Micro-spicule composition to control its shape and method for producing the same
HK1224315A1 (zh) * 2013-06-28 2017-08-18 Galderma S.A. 用於制备交联的透明质酸产物的方法
PL3049055T3 (pl) * 2013-09-27 2019-05-31 Anteis Sa Sposób otrzymywania hydrożelu do wstrzykiwań na bazie kwasu hialuronowego zawierającego lidokainę dodaną w postaci proszku oraz środek alkaliczny, sterylizowanego ciepłem
CZ2014150A3 (cs) 2014-03-11 2015-05-20 Contipro Biotech S.R.O. Konjugáty oligomeru kyseliny hyaluronové nebo její soli, způsob jejich přípravy a použití
CZ2014451A3 (cs) 2014-06-30 2016-01-13 Contipro Pharma A.S. Protinádorová kompozice na bázi kyseliny hyaluronové a anorganických nanočástic, způsob její přípravy a použití
WO2016051219A1 (en) 2014-09-30 2016-04-07 Allergan Industrie, Sas Stable hydrogel compositions including additives
FR3029928B1 (fr) 2014-12-15 2018-03-09 Teoxane Gel reticule
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
RU2715234C2 (ru) 2015-02-13 2020-02-26 Аллерган Эндюстри, Сас Имплантаты для моделирования, увеличения или коррекции частей лица, например подбородка
CZ309295B6 (cs) 2015-03-09 2022-08-10 Contipro A.S. Samonosný, biodegradabilní film na bázi hydrofobizované kyseliny hyaluronové, způsob jeho přípravy a použití
CZ2015398A3 (cs) 2015-06-15 2017-02-08 Contipro A.S. Způsob síťování polysacharidů s využitím fotolabilních chránicích skupin
US9737395B2 (en) 2015-06-26 2017-08-22 Phi Nguyen Systems and methods for reducing scarring
CZ306662B6 (cs) 2015-06-26 2017-04-26 Contipro A.S. Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití
US10130578B2 (en) 2015-07-23 2018-11-20 Johnson & Johnson Consumer Inc. Topical delivery of skin compositions having low pH
EP3328351A1 (en) 2015-07-27 2018-06-06 Galderma S.A. A process for efficient cross-linking of hyaluronic acid
CZ308106B6 (cs) 2016-06-27 2020-01-08 Contipro A.S. Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití
AR110299A1 (es) * 2016-12-02 2019-03-13 Sanofi Sa Conjugados que comprenden un agonista dual de glp-1 / glucagón, un conector y ácido hialurónico
CN106750383B (zh) * 2016-12-20 2019-02-12 大连理工大学 聚乙二醇水凝胶材料及其制备方法
KR101944008B1 (ko) * 2017-09-18 2019-01-30 (주) 제이씨바이오 히알루론산을 포함하는 투명 하이드로겔 막 및 이를 이용한 콘택트렌즈
CN107936272B (zh) * 2017-11-27 2020-11-10 华熙生物科技股份有限公司 一种用于放疗防护的3d交联透明质酸盐凝胶的制备方法及其产品
KR102524418B1 (ko) * 2017-12-29 2023-04-24 마텍스 랩 에스.피.에이 중화 단계를 포함하고 히알루론산 염기를 가지는 필러를 제조하는 방법
PL3790599T3 (pl) * 2018-05-08 2023-06-26 Fidia Farmaceutici S.P.A. Opatrunek na rany do leczenia uszkodzonej skóry
CN108774330B (zh) * 2018-08-30 2020-11-10 华熙生物科技股份有限公司 一种交联透明质酸凝胶的制备方法及所得产品和应用
EP3852725A4 (en) * 2018-09-20 2022-08-03 The Hong Kong University of Science and Technology EYE DROP COMPOSITIONS
WO2020057606A1 (en) * 2018-09-20 2020-03-26 The Hong Kong University Of Science And Technology Eyedrop compositions
KR102015857B1 (ko) * 2019-04-08 2019-08-30 (주)우성씨앤티 가교 히알루론산과 프리바이오틱스를 활성 성분으로 포함하는 화장품 조성물
EP3797800A1 (en) * 2019-05-02 2021-03-31 Institut National De La Sante Et De La Recherche Medicale - Inserm Hyaluronic acid hydrogels with prolonged antimicrobial activity
WO2020264392A1 (en) * 2019-06-26 2020-12-30 Lacerta Technologies Inc. Cross-linked hyaluronic acid hydrogels comprising proteins
CN111514364B (zh) * 2020-03-19 2022-06-10 中国人民解放军陆军军医大学第二附属医院 一种用于恶性血液病患者肛周感染的敷料及其制备方法
EP4143240B1 (en) * 2020-04-28 2023-09-20 Nanofaber S.r.L. Nanoporous microsponge particles (nmp) of biocompatible polymers as universal carriers for biomolecules delivery
WO2022174321A1 (en) * 2021-02-16 2022-08-25 Prollenium Medical Technologies, Inc. Cross-linked ha beads, process for making same and uses
CN114209869A (zh) * 2022-01-14 2022-03-22 北京极暖网络科技有限公司 自发热玻尿酸材料、制备方法及裤式卫生巾
CN117683275A (zh) * 2023-12-06 2024-03-12 江苏集萃功能材料研究所有限公司 一种注射用水凝胶、制备方法及应用
CN117700582B (zh) * 2023-12-22 2026-05-05 湖南斯洛柯有机硅有限公司 一种有机硅改性透明质酸、改性液状有机硅弹性体及其制备方法与应用
CN118403006A (zh) * 2024-03-29 2024-07-30 上海利康瑞生物工程有限公司 交联玻璃酸钠注射液用于治疗骨关节炎的用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4716224A (en) 1984-05-04 1987-12-29 Seikagaku Kogyo Co. Ltd. Crosslinked hyaluronic acid and its use
SE442820B (sv) * 1984-06-08 1986-02-03 Pharmacia Ab Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut
US4582865A (en) 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US4713448A (en) 1985-03-12 1987-12-15 Biomatrix, Inc. Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues
EP0224987B1 (en) * 1985-11-29 1992-04-15 Biomatrix, Inc. Drug delivery systems based on hyaluronan, derivatives thereof and their salts and method of producing same
JPS6345198A (ja) 1986-04-23 1988-02-26 Sumitomo Electric Ind Ltd 多元系結晶の製造方法
IT1198449B (it) 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
US5017229A (en) 1990-06-25 1991-05-21 Genzyme Corporation Water insoluble derivatives of hyaluronic acid
US5356883A (en) 1989-08-01 1994-10-18 Research Foundation Of State University Of N.Y. Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use
US5767079A (en) * 1992-07-08 1998-06-16 Celtrix Pharmaceuticals, Inc. Method of treating ophthalmic disorders using TGF -β
US5866120A (en) * 1995-11-22 1999-02-02 Advanced Corneal Systems, Inc. Method for accelerating clearance of hemorrhagic blood from the vitreous humor with hyaluronidase
IT1303735B1 (it) 1998-11-11 2001-02-23 Falorni Italia Farmaceutici S Acidi ialuronici reticolati e loro usi medici.
FR2827290B1 (fr) * 2001-07-13 2004-07-09 Pierre Jouan Biotechnologies Sa Procede d'obtention d'une fraction proteique enrichie en tgf-beta sous forme activee, fraction proteique et applications therapeutiques
JP2005525091A (ja) * 2001-12-21 2005-08-25 ノボザイムス バイオポリマー アクティーゼルスカブ 組換え宿主細胞におけるヒアルロナンの生成方法
AU2003230948A1 (en) 2002-04-17 2003-11-03 Genzyme Corporation Cross-linked hyaluronate compounds
WO2004067575A1 (en) 2003-01-31 2004-08-12 Biosphere S.P.A. Water soluble and biocompatible gels of hyaluronic acid cross-linked with bi-functional l-aminoacids or l-aminoesters
BRPI0418309B8 (pt) 2003-12-30 2021-05-25 Genzyme Corp "géis coesos de hialuronado e/ou hilano reticulados, processo para a preparação dos mesmos, bem como composições e dispositivos compreendendo os referidos géis".
CA2567532C (en) * 2004-05-20 2013-10-01 Mentor Corporation Methods for making injectable polymer hydrogels

Also Published As

Publication number Publication date
PT1817347T (pt) 2017-07-21
CN101107270B (zh) 2011-11-23
US8481080B2 (en) 2013-07-09
WO2006056204A8 (en) 2006-08-24
WO2006056204A1 (en) 2006-06-01
US20130338100A1 (en) 2013-12-19
US20090155362A1 (en) 2009-06-18
ES2636998T3 (es) 2017-10-10
CN101107270A (zh) 2008-01-16
DK1817347T3 (en) 2017-08-14
US20150190420A1 (en) 2015-07-09
EP1817347B1 (en) 2017-05-17
EP1817347A1 (en) 2007-08-15

Similar Documents

Publication Publication Date Title
PT1817347T (pt) Resumo
EP1818344A4 (en) METHOD FOR SYNTHESIZING RETICULATED HYALURONIC ACID GEL
PL1784375T3 (pl) Sposób wytwarzania kwasu mrówkowego
ME01599B (me) Postupak za dobijanje dihidropteridinona
IL197498A0 (en) Hyaluronic acid derivatives obtained via click chemistry' crosslinking
GB0614800D0 (en) Method of manufacture of polymer composites
TWI349660B (en) Process for producing acetic acid
IL182940A0 (en) Solid electrolyte and method of producing the same
IL176767A0 (en) Production method
GB0409610D0 (en) Improved method of settling commercial indebtedness
IL180742A0 (en) Method of manufacture
PL1903019T3 (pl) Sposób wytwarzania izoolefin
EP2003735A4 (en) END DEVICE AND METHOD FOR THE PRODUCTION THEREOF
IL171145A (en) Method for the production of telmisartan
TWI365182B (en) Process for producing acetic acid
ZA200609923B (en) 2-butanol production method
PT2597175T (pt) Método para a produção de um polímero revestido
ZA200709285B (en) Method for the production of pigs, and pigs
SI1794111T1 (sl) Postopek za pridobivanje ciklopentanona
EP1892255A4 (en) ACRYLIC ACID POLYMER AND MANUFACTURING METHOD THEREFOR
SI2121649T1 (sl) Postopek za pripravo benzofuran-2 karboksamidov
IL181339A0 (en) Method for the production of diarylcycloalkyl derivatives
TWI372158B (en) Method of producing film from polymer solution
ZA200700282B (en) Method for the production of dihydropteridinones
PL372014A1 (pl) Sposób wytwarzania kwasu 1-metylo-4-nitro-3-n-propylo-pirazolo-5-karboksylowego